entertainment -WSS

entertainment

author：knowledge 2025-09-08 11:05:11 - browse：93

FDA stop sign — Sarah Silbiger/Getty Images

The Food and Drug Administration is cracking down on websites that claim to sell the underlying chemicals of popular diabetes and obesity drugs like Ozempic, Wegovy, and Zepbound, saying that the websites are selling unapproved and misbranded drug products.

The regulator this week posted warning letters that it sent to two websites, Synthetix Inc. DBA Helix Chemical Supply and US Chem Labs. Though those websites say their chemicals are “for research use” and “not for human consumption,” the FDA said it found evidence on their pages showing that their products are indeed intended for human use, such as information about dosing and claims about the clinical benefits of the products.

The two websites did not immediately respond to requests for comment. The FDA said they have 15 working days to respond and detail the steps they’ve taken to address any violations.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Listen: Racing for gene therapy & a pioneering approval

hotspot

WSS

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

The nurse manager staffing crisis is hurting patients

Designating disabled people as health disparity population is crucial

Heart disease and mental health: A look at cardiac psychology

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Risky weight loss products often used by teens globally, per study

focus

entertainment

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Medicare proposal to cover medical devices draws a mixed reaction

Caregivers of transplant patients call for more support, training

Hollywood unions extend contract negotiations for actors

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Medicare proposal to cover medical devices draws a mixed reaction

Lung cancer is America's deadliest cancer. Yet so few get screened

What does generative AI mean for health care? We asked experts

Living with Hashimoto's and celiac disease, and med school, too

focus

ProMED sees offers of support, but its future remains unclear

Vaccine critic Robert F. Kennedy Jr. says he'll chair Trump vaccine panel

The boys, now 6, who are gene therapy’s ‘edge case’ problem

As JPM 2024 winds down, some health tech firms project optimism

Fauci’s Covid grilling leads GOP to weigh foreign research rules

New menopause drug shows promise in relief for hot flashes

hotspot

hotspot

focus

entertainment